Public Event Detail
HCA Healthcare, Inc. $HCA Shares Sold by Arax Advisory Partners
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Event summary
Arax Advisory Partners reduced its stake in HCA Healthcare by 40.8% in the fourth quarter, selling 3,880 shares and leaving it with 5,638 shares valued at approximately $2.63 million. Despite several institutional investors adjusting their holdings, major firms like State Street, Capital World Investors, and Geode Capital remain significant shareholders, with institutional and hedge funds collectively owning 62.73% of HCA stock. HCA reported $7.15 EPS on $19.11 billion in revenue for the quarter, missing profit but exceeding revenue expectations, and analysts maintain a "Moderate Buy" rating with an average target price of $506.14.